Trial intelligence / Profile preview

CTP0303 vs Orafang for Bowel Preparation

NCT05670470Phase 3Completed

Sponsor
Taejoon Pharmaceutical Co., Ltd.
Start
Sep 2022
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of CTP-0303 in bowel preparation, sponsored by Taejoon Pharmaceutical Co., Ltd.. Started Sep 2022; status: completed.

02

Drugs

CTP-0303
03

Conditions

bowel preparation

Beyond the preview

Go deeper on NCT05670470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05670470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call